AbCellera
AI-powered platform for antibody discovery and development to create new medicines.
Rate
About
AbCellera is a technology company that partners with drug developers to discover and develop antibody therapeutics. Their AI-powered drug discovery platform integrates high-throughput screening, genomics, and AI to accelerate the identification of therapeutic antibodies from natural immune responses.
Technology stack
detected 2026-06-22Est. monthly stack spend~$160/mo
CDN
Cloudflare
Email
Google Workspace
Stack
Webflow
Analytics
Google Tag Manager
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does AbCellera do?
AbCellera is a technology company that partners with drug developers to discover and develop antibody therapeutics. Their AI-powered drug discovery platform integrates high-throughput screening, genomics, and AI to accelerate the identification of therapeutic antibodies from natural immune responses.
How much funding has AbCellera raised?
AbCellera has raised a total of $10M in funding. The most recent round on record is Series A.
Where is AbCellera headquartered?
AbCellera is headquartered in Vancouver, Canada.
When was AbCellera founded?
AbCellera was founded in 2012.
What industry does AbCellera operate in?
AbCellera operates in Biotech, Drug Discovery, Genomics, AI Drug Discovery, Antibody Therapeutics, Single-Cell Analysis.